Xiaobing Qin

Cisplatin-resistant lung cancer cell–derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100–5p-dependent manner

Xiaobing Qin, Shaorong Yu, Leilei Zhou et al. · International Journal of Nanomedicine · 2017 · 237 citations · Full text

Cisplatin Resistance, 5P-dependent Manner, Exosomes +15

EGFR E746-A750 deletion in lung cancer represses antitumor immunity through the exosome-mediated inhibition of dendritic cells

Shaorong Yu, Huanhuan Sha, Xiaobing Qin et al. · Oncogene · 2020 · 66 citations

Oncology, Medicine, Immunology +9

Exosome‑mediated gefitinib resistance in lung cancer HCC827 cells via delivery of miR‑21

Changwen Jing, Haixia Cao, Xiaobing Qin et al. · Oncology Letters · 2018 · 57 citations · Full text

Oncology, Health Sciences, Medicine +13

MicroRNA-106b-5p regulates cisplatin chemosensitivity by targeting polycystic kidney disease-2 in non-small-cell lung cancer

Shaorong Yu, Xiaobing Qin, Tingting Chen et al. · Anti-Cancer Drugs · 2017 · 45 citations · Full text

Microrna-106b-5p Regulates, Non-small-cell Lung Cancer, Polycystic Kidney Disease-2 +15

Comparative analysis of microRNA expression profiles between A549, A549/DDP and their respective exosomes

Xiaobing Qin, Shaorong Yu, Xiaoyue Xu et al. · Oncotarget · 2017 · 42 citations · Full text

Molecular Biology, Cancer Biology, Tumor Biology +19